Trial Profile
Clinical Trials Insight: 700034793
Status:
Active, no longer recruiting
Phase of Trial:
Phase I
Latest Information Update: 24 Jun 2008
Price :
$35
*
At a glance
- Drugs AP 768 (Primary)
- Indications Allergic rhinitis; Asthma
- Focus Adverse reactions
- Sponsors Actimis Pharmaceuticals
- 24 Jun 2008 New trial record.